|
Facebook
Twitter
Linkedin
|
 |
 |
 |
 |
Medipattern 
Medipattern(R) & Navix Diagnostix, Inc. Sign Data Collection Agreement
Medipattern(R) & Navix Diagnostix, Inc. Sign Data Collection Agreement
Medipattern(R) & Navix Diagnostix, Inc. Sign Data Collection Agreement
Wednesday, 25 February 2009 04:08 | 
| Company News - Medipattern |
The Medipattern Corporation and NAVIX Diagnostix, Inc. announces NAVIX will collect data for the development of Medipattern's vascular imaging tool, VasculariQ(TM).
The Medipattern Corporation ,a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, and NAVIX Diagnostix, Inc. the leading provider of vascular ultrasound outsourcing solutions in the northeastern U.S. are pleased to announce that NAVIX will collect data for the development of Medipattern's vascular imaging tool, VasculariQ(TM). The American Heart Association cites an estimated 80,700,000 American adults (one in three) have one or more types of cardiovascular disease (CVD) and the statistics echo throughout the global population. Medipattern recently announced an agreement with GE Healthcare to create a set of image quantification tools to help physicians visualize plaque and other conditions that can block the vascular system. Vascular diseases are estimated to be among the highest causes of lifestyle impairment, including stroke, amputation and heart attack.
"Under the agreement Medipattern will receive real-time ultrasound images and supporting information for known vascular diseases." stated Bob Kane, Senior Vice President of Clinical Services and Business Development of NAVIX.
"Under the agreement with GE Healthcare, GE and Medipattern have been working on a proof of concept for the vascular quantification tool that we shared with Bob Kane and his colleagues at NAVIX." commented Jeff Collins, CEO of The Medipattern Corporation.
About NAVIX Diagnostix
NAVIX Diagnostix, Inc. is a privately held company providing cardiovascular management solutions for hospitals and medical practices, combining a passion for patient care with operational excellence. Navix' Vascular Early Detection Initiative (VEDI(TM)), is a routine, risk-focused screening program aimed at early detection for individuals most at risk for peripheral arterial disease (PAD). Navix was responsible for deploying one of the first Intersocietal Commission for the Accreditation of Vascular Labs (ICAVL) accredited screening programs in the U.S.
About The Medipattern Corporation:
Medipattern is a pioneer in the development of medical software solutions that help improve imaging workflow and productivity. Our first-to-market, award-winning B-CAD® advances breast ultrasound computer aided detection (CAD) by streamlining workflow and organizing information into a comprehensive patient record. Medipattern uses its Cadenza(TM) CAD Technology to power the digital conversion in medical communications. B-CAD automatically creates fully digital standardized worksheets and reports that make every practice more efficient, productive and ultimately more effective.
"Under the agreement Medipattern will receive real-time ultrasound images and supporting information for known vascular diseases." stated Bob Kane, Senior Vice President of Clinical Services and Business Development of NAVIX.
"Under the agreement with GE Healthcare, GE and Medipattern have been working on a proof of concept for the vascular quantification tool that we shared with Bob Kane and his colleagues at NAVIX." commented Jeff Collins, CEO of The Medipattern Corporation.
About NAVIX Diagnostix
NAVIX Diagnostix, Inc. is a privately held company providing cardiovascular management solutions for hospitals and medical practices, combining a passion for patient care with operational excellence. Navix' Vascular Early Detection Initiative (VEDI(TM)), is a routine, risk-focused screening program aimed at early detection for individuals most at risk for peripheral arterial disease (PAD). Navix was responsible for deploying one of the first Intersocietal Commission for the Accreditation of Vascular Labs (ICAVL) accredited screening programs in the U.S.
About The Medipattern Corporation:
Medipattern is a pioneer in the development of medical software solutions that help improve imaging workflow and productivity. Our first-to-market, award-winning B-CAD® advances breast ultrasound computer aided detection (CAD) by streamlining workflow and organizing information into a comprehensive patient record. Medipattern uses its Cadenza(TM) CAD Technology to power the digital conversion in medical communications. B-CAD automatically creates fully digital standardized worksheets and reports that make every practice more efficient, productive and ultimately more effective.
Source: Medipattern Corporation
